Vitamin D in atopic dermatitis, asthma and allergic diseases

Immunology and Allergy Clinics of North America

Volumn 30, Issue 3, 2010, Pages 397-409

  Searing, Daniel A ^a   Leung, Donald Y M ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b Children's Hospital Colorado   (United States)

Author keywords

Allergy; Asthma; Atopic dermatitis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; COLECALCIFEROL; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PLACEBO; PLATELET DERIVED GROWTH FACTOR; RANTES; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ALLERGIC DISEASE; ANTIBODY PRODUCTION; ASTHMA; ATOPIC DERMATITIS; BODY MASS; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRATUM CORNEUM; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; WILD TYPE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ASTHMA; DERMATITIS, ATOPIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOMODULATION; INTERMEDIATE FILAMENT PROTEINS; POLYMORPHISM, GENETIC; PREVALENCE; RECEPTORS, CALCITRIOL; RHINITIS, ALLERGIC, SEASONAL; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77955475905     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2010.05.005     Document Type: Review

References (73)

1. Mohr S.B. A brief history of vitamin D and cancer prevention. Ann Epidemiol 2009, 19(2):79-83.
2. Palm T. The geographical distribution and etiology of rickets. Practitioner 1890, 45(270-9):321-342.
3. Mozolowski W., Sniadecki J. On the cure of rickets. Nature 1939, 143:121.
4. Mellanby T. The part played by an 'accessory factor' in the production of experimental rickets. J Physiol 1918, 52:11-14.
5. McCollum E.V., Simmonds N., Becker J.E., et al. Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 1922, 53:293-312.
6. Windaus A., Schenck F., von Werder F. On the antirachitic active irradiation product from 7-dehydrocholesterol. Physiol Chem 1936, 241:100-103.
7. Holick M. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002, 9(1):87-98.
8. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
9. Godar D.E., Wengraitis S.P., Shreffler J., et al. UV doses of Americans. Photochem Photobiol 2001, 73(6):621-629.
10. Godar D.E. UV doses of American children and adolescents. Photochem Photobiol 2001, 74(6):787-793.
11. Ginde A.A., Liu M.C., Camargo C.A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169(6):626-632.
12. Kumar J., Muntner P., Kaskel F.J., et al. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics 2009, 124:e362-e370.
13. NHANES Analytical note for NHANES 2000-2006 and NHANES III (1988-1994) 25-hydroxyvitamin D analysis 2009. Available at:, Accessed September 25, 2009. http://www.cdc.gov/nchs/data/nhanes/nhanes3/VitaminD_analyticnote.pdf.
14. Searing DA, Murphy J, Hauk P, et al. Vitamin D levels in children with asthma, atopic dermatitis, and food allergy. J Allergy Clin Immunol 2010, 125(2):AB44.
15. Wagner C.L., Greer F.R. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008, 122(5):1142-1152.
16. NIH Dietary supplement fact sheet: vitamin D 2009. Available at:, Accessed October 25, 2009. http://dietary-supplements.info.nih.gov/factsheets/vitamind.asp%23h3.
17. Vieth R., Bischoff-Ferrari H., Boucher B.J., et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007, 85(3):649-650.
18. Barger-Lux M.J., Heaney R.P., Dowell S., et al. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 1998, 8(3):222-230.
19. Litonjua A.A., Weiss S.T. Is vitamin D deficiency to blame for the asthma epidemic?. J Allergy Clin Immunol 2007, 120(5):1031-1035.
20. Asher M. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998, 12(2):315-335.
21. Von Mutius E. Epidemiology of allergic disease. Pediatric allergy principles and practice 2003, 1-9. Mosby, St. Louis (MO). D.Y.M. Leung, H.A. Sampson, R.S. Geha (Eds.).
22. Zhao T., Wang H.J., Chen Y., et al. Prevalence of childhood asthma, allergic rhinitis and eczema in Urumqi and Beijing. J Paediatr Child Health 2000, 36(2):128-133.
23. Camargo C.A., Rifas-Shiman S.L., Litonjua A.A., et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr 2007, 85(3):788-795.
24. Misra M., Pacaud D., Petryk A., et al. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008, 122(2):398-417.
25. Baker A.R., McDonnell D.P., Hughes M., et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A 1988, 85(10):3294-3298.
26. Bhalla A.K., Amento E.P., Clemens T.L., et al. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983, 57(6):1308-1310.
27. Brennan A., Katz D.R., Nunn J.D., et al. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 1987, 61(4):457-461.
28. Adorini L., Penna G., Giarratana N., et al. Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands. J Steroid Biochem Mol Biol 2004, 89-90(1-5):437-441.
29. Adams J.S., Gacad M.A. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 1985, 161(4):755-765.
30. Chen K.S., DeLuca H.F. Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim Biophys Acta 1995, 1263(1):1-9.
31. Provvedini D.M., Tsoukas C.D., Deftos L.J., et al. 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 1983, 221(4616):1181-1183.
32. Tsoukas C.D., Provvedini D.M., Manolagas S.C. 1,25-Dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984, 224(4656):1438-1440.
33. Mahon B.D., Wittke A., Weaver V., et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003, 89(5):922-932.
34. Froicu M., Weaver V., Wynn T.A., et al. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003, 17(12):2386-2392.
35. Boonstra A., Barrat F.J., Crain C., et al. 1alpha, 25-Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001, 167(9):4974-4980.
36. Matheu V., Back O., Mondoc E., et al. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J Allergy Clin Immunol 2003, 112(3):585-592.
37. 3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res 2002, 52(1):12-18.
38. Hypponen E., Sovio U., Wjst M., et al. Infant vitamin D supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann N Y Acad Sci 2004, 1037:84-95.
39. Kull I., Bergstrom A., Melen E., et al. Early-life supplementation of vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood. J Allergy Clin Immunol 2006, 118(6):1299-1304.
40. Ginde A.A., Mansbach J.M., Camargo C.A. Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep 2009, 9(1):81-87.
41. Weisberg P., Scanlon K.S., Li R., et al. Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am J Clin Nutr 2004, 80(6 Suppl):1697S-1705S.
42. Camargo C.A., Clark S., Kaplan M.S., et al. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J Allergy Clin Immunol 2007, 120(1):131-136.
43. Oren E., Banerji A., Camargo C.A. Vitamin D and atopic disorders in an obese population screened for vitamin D deficiency. J Allergy Clin Immunol 2008, 121(2):533-534.
44. Wjst M. The vitamin D slant on allergy. Pediatr Allergy Immunol 2006, 17(7):477-483.
45. Xystrakis E., Kusumakar S., Boswell S., et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006, 116(1):146-155.
46. Zhang Y., Goleva E., Leung D.Y. Vitamin D enhances glucocorticoid-induced mitogen-activated protein kinase phosphatase-1 (MKP-1) expression and their anti-proliferative effect in peripheral blood mononuclear cells. J Allergy Clin Immunol 2009, 123(2):S121.
47. Wittke A., Weaver V., Mahon B.D., et al. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J Immunol 2004, 173(5):3432-3436.
48. Black P.N., Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey. Chest 2005, 128(6):3792-3798.
49. Brehm J.M., Celedon J.C., Soto-Quiros M.E., et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009, 179(9):765-771.
50. Devereux G., Litonjua A.A., Turner S.W., et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr 2007, 85(3):853-859.
51. Gale C.R., Robinson S.M., Harvey N.C., et al. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr 2008, 62(1):68-77.
52. Stumpf W.E., Sar M., Reid F.A., et al. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979, 206(4423):1188-1190.
53. Gurlek A., Pittelkow M.R., Kumar R. Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev 2002, 23(6):763-786.
54. Zhang J.Z., Maruyama K., Ono I., et al. Production and secretion of platelet-derived growth factor AB by cultured human keratinocytes: regulatory effects of phorbol 12-myristate 13-acetate, etretinate, 1,25-dihydroxyvitamin D3, and several cytokines. J Dermatol 1995, 22(5):305-309.
55. Geilen C.C., Bektas M., Wieder T., et al. 1alpha,25-dihydroxyvitamin D3 induces sphingomyelin hydrolysis in HaCaT cells via tumor necrosis factor alpha. J Biol Chem 1997, 272(14):8997-9001.
56. Zhang J.Z., Maruyama K., Ono I., et al. Regulatory effects of 1,25-dihydroxyvitamin D3 and a novel vitamin D3 analogue MC903 on secretion of interleukin-1 alpha (IL-1 alpha) and IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1). J Dermatol Sci 1994, 7(1):24-31.
57. Komine M., Watabe Y., Shimaoka S., et al. The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes. Arch Dermatol Res 1999, 291(9):500-506.
58. Fukuoka M., Ogino Y., Sato H., et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 1998, 138(1):63-70.
59. Bikle D.D., Chang S., Crumrine D., et al. 25-Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol 2004, 122(4):984-992.
60. Bikle D.D., Pillai S., Gee E., et al. Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. Endocrinology 1989, 124(2):655-660.
61. Gregori S., Casorati M., Amuchastegui S., et al. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001, 167(4):1945-1953.
62. Elias P.M., Hatano Y., Williams M.L. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008, 121(6):1337-1343.
63. O'Regan G.M., Sandilands A., McLean W.H., et al. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008, 122(4):689-693.
64. Irvine A.D. Fleshing out filaggrin phenotypes. J Invest Dermatol 2007, 127(3):504-507.
65. Schauber J., Gallo R.L. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2008, 122(2):261-266.
66. Ong P.Y., Ohtake T., Brandt C., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002, 347(15):1151-1160.
67. Howell M.D., Wollenberg A., Gallo R.L., et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 2006, 117(4):836-841.
68. Howell M.D., Gallo R.L., Boguniewicz M., et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 2006, 24(3):341-348.
69. Beck L.A., Boguniewicz M., Hata T., et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol 2009, 124(2):260-269.
70. Wang T.T., Nestel F.P., Bourdeau V., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004, 173(5):2909-2912.
71. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311(5768):1770-1773.
72. Hata T.R., Kotol P., Jackson M., et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008, 122(4):829-831.
73. Sidbury R., Sullivan A.F., Thadhani R.I., et al. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol 2008, 159(1):245-247.